Cargando…

The impact of SARS-CoV-2 3CL protease mutations on nirmatrelvir inhibitory efficiency. Computational insights into potential resistance mechanisms

The use of antiviral drugs can promote the appearance of mutations in the target protein that increase the resistance of the virus to the treatment. This is also the case of nirmatrelvir, a covalent inhibitor of the 3CL protease, or main protease, of SARS-CoV-2. In this work we show how the by-resid...

Descripción completa

Detalles Bibliográficos
Autores principales: Ramos-Guzmán, Carlos A., Andjelkovic, Milorad, Zinovjev, Kirill, Ruiz-Pernía, J. Javier, Tuñón, Iñaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Royal Society of Chemistry 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9993853/
https://www.ncbi.nlm.nih.gov/pubmed/36908962
http://dx.doi.org/10.1039/d2sc06584c